In 2025, the hair loss market is expected to top US$12 billion. More than ever, people are concerned about their looks, lifestyle and general health.
Rogaine and versions of private label Minoxidil control 98% of the topical hair growth market in the U.S.
No new FDA-approved drug has been marketed in the last 40 years.
Average spent for hair loss products in the US per patient, per year.
We are part
of the solution
LOOKING TO INVEST?
Looking to invest?